Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
TBPH
TBPH
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
TBPH News
Jones Trading Downgrades Theravance to Hold Amid $929M Acquisition
Jun 29 2026
seekingalpha
Investor Rights Law Firm Investigates Multiple Companies
Jun 29 2026
PRnewswire
Investigation into Theravance Biopharma's Transaction with Zymeworks
Jun 29 2026
PRnewswire
Theravance Biopharma Acquired by Zymeworks for $17.00 per Share
Jun 29 2026
stocktwits
Zymeworks Acquires Theravance Biopharma for $929M
Jun 29 2026
seekingalpha
Theravance Biopharma Acquired by Zymeworks for $17 per Share
Jun 29 2026
PRnewswire
Zymeworks Acquires Theravance Biopharma for $929 Million
Jun 29 2026
Newsfilter
Theravance Biopharma to be Acquired by Zymeworks for $17.00 per Share
Jun 29 2026
Newsfilter
Theravance Biopharma Under Investigation for Securities Fraud Claims
May 07 2026
PRnewswire
Theravance Biopharma Q1 Earnings Analysis
May 07 2026
seekingalpha
Theravance Biopharma Reports Strong Q1 2026 Financial Results and Strategic Restructuring
May 07 2026
PRnewswire
THERAVANCE BIOPHARMA INC ANTICIPATES AROUND 60% DECREASE IN OPERATING EXPENSES DUE TO RESTRUCTURING
May 07 2026
moomoo
Theravance Biopharma Under Investigation for Securities Fraud Claims
May 01 2026
PRnewswire
Summers Value Fund LP Reports -2.7% Return in Q1 2026, Underperforming Indices
Apr 29 2026
seekingalpha
Theravance Biopharma Under Investigation for Securities Fraud Claims
Apr 28 2026
Globenewswire
Theravance Biopharma Under Investigation for Securities Fraud
Apr 21 2026
Globenewswire
Show More News
